A5032409490- Gastric Cancer Management and Outcomes
- Gastrointestinal Tumor Research and Treatment
- Metastasis and carcinoma case studies
- Sarcoma Diagnosis and Treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Esophageal and GI Pathology
- Cancer Genomics and Diagnostics
- Pancreatic and Hepatic Oncology Research
- Neuroendocrine Tumor Research Advances
- Gastrointestinal disorders and treatments
- Esophageal Cancer Research and Treatment
- Genetic factors in colorectal cancer
- Helicobacter pylori-related gastroenterology studies
- Intraperitoneal and Appendiceal Malignancies
- Cancer Cells and Metastasis
- Nutrition and Health in Aging
- Colorectal Cancer Surgical Treatments
- Cancer Diagnosis and Treatment
- Cancer, Lipids, and Metabolism
- Breast Cancer Treatment Studies
- Vascular Malformations and Hemangiomas
- Breast Lesions and Carcinomas
- Colorectal Cancer Treatments and Studies
- Enhanced Recovery After Surgery
- Colorectal and Anal Carcinomas
Shizuoka Cancer Center
2016-2025
Shizuoka Medical Center
2022
Cleveland Clinic
2020
Shizuoka General Hospital
2018
Kanazawa University
1998-2003
Kanazawa Hospital
2002
Kanazawa University Hospital
1998-1999
Background Recently, rapid advances have been made in metabolomics-based, easy-to-use early cancer detection methods using blood samples. Among metabolites, profiling of plasma free amino acids (PFAAs) is a promising approach because PFAAs link all organ systems and important roles metabolism. Furthermore, PFAA profiles are known to be influenced by specific diseases, including cancers. Therefore, the purpose present study was determine characteristics patients possibility this information...
The incidence of adenocarcinoma the esophagogastric junction (AEG) has been increasing worldwide. We investigated clinicopathological characteristics patients with Siewert type II and III AEGs clarified optimal intra-abdominal lymph node dissection in these patients.